Fully synthetic Tn-based three-component cancer vaccine using covalently linked TLR4 ligand MPLA and iNKT cell agonist KRN-7000 as built-in adjuvant effectively protects mice from tumor development-Reference-Cited by-同舟云学术

Fully synthetic Tn-based three-component cancer vaccine using covalently linked TLR4 ligand MPLA and iNKT cell agonist KRN-7000 as built-in adjuvant effectively protects mice from tumor development

Published:2022-12 Issue:12 Volume:12 Page:4432-4445
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Yang Deying,Luo Xiang,Lian Qinghai,Gao Lingqiang,Wang Chengxin,Qi Xiaoxiao,Zhang Rong,Liu Zhongqiu,Liao Guochao^ORCID

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference50 articles.

1. Therapeutic cancer vaccines;Saxena;Nat Rev Cancer,2021

2. Advances in the development of personalized neoantigen-based therapeutic cancer vaccines;Blass;Nat Rev Clin Oncol,2021

3. Recent advance in tumor-associated carbohydrate antigens (TACAs)-based antitumor vaccines;Feng;ACS Chem Biol,2016

4. Glycans in cancer and inflammation-potential for therapeutics and diagnostics;Dube;Nat Rev Drug Discov,2005

5. Identification of tumour-associated T-cell epitopes for vaccine development;Stevanovic;Nat Rev Cancer,2002

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic immune augmentation enabled by covalently conjugating TLR4 and NOD2 agonists;European Journal of Medicinal Chemistry;2024-11

2. Conjugation of TLR7 and TLR7/8 agonists onto weak protein antigen via versatile oxime ligation for enhanced vaccine efficacy;International Journal of Biological Macromolecules;2024-10

3. Simultaneous enhancement of cellular and humoral immunity by the lymph node-targeted cholesterolized TLR7 agonist liposomes;Acta Pharmaceutica Sinica B;2024-09

4. Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2021–2022;Mass Spectrometry Reviews;2024-06-24

5. Design, Synthesis, and Bioactivity Evaluation of a TF-Based Cancer Vaccine Candidate Using Lipid A Mimetics As a Built-In Adjuvant;Journal of Medicinal Chemistry;2024-06-17